Work

Low-dose Olanzapine and Sertraline Combination Therapy for Metabolic Disturbance in Patients with Schizophrenia: A Large-scale, Open-label Randomized Trial

Year: 2025

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Current Neuropharmacology

DOI: 10.2174/011570159x395131251008050155

Authors: Xiaoni Guan, Meihong Xiu, Fengchun Wu

Institutions: Peking University, Beijing HuiLongGuan Hospital, Guangzhou Medical University

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415838681

FWCI:

Cites:

Cited by:

Related to: